Spreading depression

Imaging and blockade in the rat neocortical brain slice

Trent R Anderson, R. David Andrew

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Spreading depression (SD) is a profound but transient depolarization of neurons and glia that migrates across the cortical and subcortical gray at 2-5 mm/min. Under normoxic conditions, SD occurs during migraine aura where it precedes migraine pain but does not damage tissue. During stroke and head trauma, however, SD can arise repeatedly near the site of injury and may promote neuronal damage. We developed a superfused brain slice preparation that can repeatedly support robust SD during imaging and electrophysiological recording to test drugs that may block SD. Submerged rat neocortical slices were briefly exposed to artificial cerebrospinal fluid (ACSF) with KC1 elevated to 26 mM. SD was evoked within 2 min, recorded in layers II/III both as a negative DC shift and as a propagating front of elevated light transmittance (LT) representing transient cell swelling in all cortical layers. An SD episode was initiated focally and could be repeatedly evoked and imaged with no damage to slices. As reported in vivo, pretreatment with one of several N-methyl-D-aspartate (NMDA) receptor antagonists blocked SD, but a non-NMDA glutamate receptor antagonist (CNQX) had no effect. NMDA receptor (NMDAR) activation does not initiate SD nor are NMDAR antagonists tolerated therapeutically so we searched for more efficacious drugs to block SD generation. Pretreatment with the sigma-one receptor (σ1R) agonists dextromethorphan (10-100 μM), carbetapentane (100 μM), or 4-IBP (30 μM) blocked SD, even when KC1 exposure was extended beyond 5 min. The block was independent of NMDA receptor antagonism. Two σ1R antagonists [(+)-3PPP and BD-1063] removed this block but had no effect upon SD alone. Remarkably, the σ1R agonists also substantially reduced general cell swelling evoked by bath application of 26 mM KCl. More potent σ1R ligands that are therapeutically tolerated could prove useful in reducing SD associated with migraine and be of potential use in stroke or head trauma.

Original languageEnglish (US)
Pages (from-to)2713-2725
Number of pages13
JournalJournal of Neurophysiology
Volume88
Issue number5
StatePublished - Nov 1 2002
Externally publishedYes

Fingerprint

N-Methyl-D-Aspartate Receptors
Migraine Disorders
Brain
Craniocerebral Trauma
Stroke
sigma Receptors
Dextromethorphan
6-Cyano-7-nitroquinoxaline-2,3-dione
D-Aspartic Acid
Excitatory Amino Acid Antagonists
Baths
Neuroglia
Pharmaceutical Preparations
Cerebrospinal Fluid
Epilepsy
Ligands
Neurons
Light
Pain
Wounds and Injuries

ASJC Scopus subject areas

  • Physiology
  • Neuroscience(all)

Cite this

Spreading depression : Imaging and blockade in the rat neocortical brain slice. / Anderson, Trent R; Andrew, R. David.

In: Journal of Neurophysiology, Vol. 88, No. 5, 01.11.2002, p. 2713-2725.

Research output: Contribution to journalArticle

@article{08292af34c6f4a9ea93c0ea98bb10908,
title = "Spreading depression: Imaging and blockade in the rat neocortical brain slice",
abstract = "Spreading depression (SD) is a profound but transient depolarization of neurons and glia that migrates across the cortical and subcortical gray at 2-5 mm/min. Under normoxic conditions, SD occurs during migraine aura where it precedes migraine pain but does not damage tissue. During stroke and head trauma, however, SD can arise repeatedly near the site of injury and may promote neuronal damage. We developed a superfused brain slice preparation that can repeatedly support robust SD during imaging and electrophysiological recording to test drugs that may block SD. Submerged rat neocortical slices were briefly exposed to artificial cerebrospinal fluid (ACSF) with KC1 elevated to 26 mM. SD was evoked within 2 min, recorded in layers II/III both as a negative DC shift and as a propagating front of elevated light transmittance (LT) representing transient cell swelling in all cortical layers. An SD episode was initiated focally and could be repeatedly evoked and imaged with no damage to slices. As reported in vivo, pretreatment with one of several N-methyl-D-aspartate (NMDA) receptor antagonists blocked SD, but a non-NMDA glutamate receptor antagonist (CNQX) had no effect. NMDA receptor (NMDAR) activation does not initiate SD nor are NMDAR antagonists tolerated therapeutically so we searched for more efficacious drugs to block SD generation. Pretreatment with the sigma-one receptor (σ1R) agonists dextromethorphan (10-100 μM), carbetapentane (100 μM), or 4-IBP (30 μM) blocked SD, even when KC1 exposure was extended beyond 5 min. The block was independent of NMDA receptor antagonism. Two σ1R antagonists [(+)-3PPP and BD-1063] removed this block but had no effect upon SD alone. Remarkably, the σ1R agonists also substantially reduced general cell swelling evoked by bath application of 26 mM KCl. More potent σ1R ligands that are therapeutically tolerated could prove useful in reducing SD associated with migraine and be of potential use in stroke or head trauma.",
author = "Anderson, {Trent R} and Andrew, {R. David}",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "88",
pages = "2713--2725",
journal = "Journal of Neurophysiology",
issn = "0022-3077",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Spreading depression

T2 - Imaging and blockade in the rat neocortical brain slice

AU - Anderson, Trent R

AU - Andrew, R. David

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Spreading depression (SD) is a profound but transient depolarization of neurons and glia that migrates across the cortical and subcortical gray at 2-5 mm/min. Under normoxic conditions, SD occurs during migraine aura where it precedes migraine pain but does not damage tissue. During stroke and head trauma, however, SD can arise repeatedly near the site of injury and may promote neuronal damage. We developed a superfused brain slice preparation that can repeatedly support robust SD during imaging and electrophysiological recording to test drugs that may block SD. Submerged rat neocortical slices were briefly exposed to artificial cerebrospinal fluid (ACSF) with KC1 elevated to 26 mM. SD was evoked within 2 min, recorded in layers II/III both as a negative DC shift and as a propagating front of elevated light transmittance (LT) representing transient cell swelling in all cortical layers. An SD episode was initiated focally and could be repeatedly evoked and imaged with no damage to slices. As reported in vivo, pretreatment with one of several N-methyl-D-aspartate (NMDA) receptor antagonists blocked SD, but a non-NMDA glutamate receptor antagonist (CNQX) had no effect. NMDA receptor (NMDAR) activation does not initiate SD nor are NMDAR antagonists tolerated therapeutically so we searched for more efficacious drugs to block SD generation. Pretreatment with the sigma-one receptor (σ1R) agonists dextromethorphan (10-100 μM), carbetapentane (100 μM), or 4-IBP (30 μM) blocked SD, even when KC1 exposure was extended beyond 5 min. The block was independent of NMDA receptor antagonism. Two σ1R antagonists [(+)-3PPP and BD-1063] removed this block but had no effect upon SD alone. Remarkably, the σ1R agonists also substantially reduced general cell swelling evoked by bath application of 26 mM KCl. More potent σ1R ligands that are therapeutically tolerated could prove useful in reducing SD associated with migraine and be of potential use in stroke or head trauma.

AB - Spreading depression (SD) is a profound but transient depolarization of neurons and glia that migrates across the cortical and subcortical gray at 2-5 mm/min. Under normoxic conditions, SD occurs during migraine aura where it precedes migraine pain but does not damage tissue. During stroke and head trauma, however, SD can arise repeatedly near the site of injury and may promote neuronal damage. We developed a superfused brain slice preparation that can repeatedly support robust SD during imaging and electrophysiological recording to test drugs that may block SD. Submerged rat neocortical slices were briefly exposed to artificial cerebrospinal fluid (ACSF) with KC1 elevated to 26 mM. SD was evoked within 2 min, recorded in layers II/III both as a negative DC shift and as a propagating front of elevated light transmittance (LT) representing transient cell swelling in all cortical layers. An SD episode was initiated focally and could be repeatedly evoked and imaged with no damage to slices. As reported in vivo, pretreatment with one of several N-methyl-D-aspartate (NMDA) receptor antagonists blocked SD, but a non-NMDA glutamate receptor antagonist (CNQX) had no effect. NMDA receptor (NMDAR) activation does not initiate SD nor are NMDAR antagonists tolerated therapeutically so we searched for more efficacious drugs to block SD generation. Pretreatment with the sigma-one receptor (σ1R) agonists dextromethorphan (10-100 μM), carbetapentane (100 μM), or 4-IBP (30 μM) blocked SD, even when KC1 exposure was extended beyond 5 min. The block was independent of NMDA receptor antagonism. Two σ1R antagonists [(+)-3PPP and BD-1063] removed this block but had no effect upon SD alone. Remarkably, the σ1R agonists also substantially reduced general cell swelling evoked by bath application of 26 mM KCl. More potent σ1R ligands that are therapeutically tolerated could prove useful in reducing SD associated with migraine and be of potential use in stroke or head trauma.

UR - http://www.scopus.com/inward/record.url?scp=0036850164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036850164&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 2713

EP - 2725

JO - Journal of Neurophysiology

JF - Journal of Neurophysiology

SN - 0022-3077

IS - 5

ER -